ClinicalTrialsFinder

Microangiopathy Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Safety and Efficacy of Eculizumab in High-risk TA-TMA

Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
First Affiliated Hospital of Zhejiang University24 enrolled8 locationsNCT07707687